The epidemiology and pathogenesis of candidiasis: Applications in prevention and treatment

Bulletin de l'Institut Pasteur

Volumn 96, Issue 4, 1998, Pages 249-256

  Matthews, R ^a   Burnie, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Candida albicans; Candidiasis; Epidemiology; Pathogenesis; Prevention; Review; Treatment; Virulence factor

Indexed keywords

ADHESIN; AMPHOTERICIN B; ASPARTIC PROTEINASE; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; FUNGAL DNA; HEAT SHOCK PROTEIN 90; MANNAN; MONOCLONAL ANTIBODY; POVIDONE IODINE; VIRULENCE FACTOR;

BIOTYPOLOGY; CANDIDA ALBICANS; CANDIDIASIS; DNA FINGERPRINTING; DNA SEQUENCE; HAND WASHING; HUMAN; INFECTION CONTROL; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; REVIEW; SEROTYPING;

EID: 0032193454     PISSN: 00202452     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-2452(99)80005-0     Document Type: Review

References (53)

1. [1] Edwards, J.E. (1991), Invasive Candida infections. Evolution of a fungal pathogen. N. Engl. J. Med., 324, 1060-1062.
2. [2] Verfaillie, C., Weisdorf, D., Haake, R., Hostetter, M., Ramsay, N.K. & McGlave, P. (1991), Candida infections in bone marrow transplant recipients. Bone Marrow Tranplant., 8, 177-184.
3. [3] Sobel, J.D. (1992), Pathogenesis and treatment of vulvovaginal candidiasis. Clin. Infect. Dis., 14, S148-153.
4. [4] Martins, M.D. & Rex, J.H. (1996), Resistance to antifungal agents in the critical care setting: problems and perspectives. New Horizons, 4, 338-344.
5. [5] Prentice, H.G., Hann, I.M., Herbrecht, R. et al. (1997), A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Brit. J. Haematol., 98, 711-718.
6. [6] Merz, W.G. & Sanford, G.R. (1979), Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J. Clin. Microbiol., 9, 677-680.
7. [7] Wade, J.C. (1993), Epidemiology of Candida infections, in "Candidiasis: Pathogenesis, Diagnosis and Treatment" (G.P. Bodey) (pp. 85-107). 2nd edition, Raven Press, New York.
8. [8] Rippon, J.W. (1988), Candidiasis and the pathogenic yeasts, in "Medical Mycology: the pathogenic fungi and the pathogenic actinomycetes" (J.W. Rippon) (pp. 532-581). 3rd edition, W.B. Saunders, Philadelphia.
9. [9] Merz, W.G. (1990), Candida strain delineation. Clin. Microbiol. Rev., 3, 321-334.
10. [10] Odds, F.C. (1987), Candida infections: an overview. Crit. Rev. Microbiol., 15, 1-5.
11. [11] Hasenclever, H.F. & Mitchell, W.O. (1961), Antigenic studies of Candida. - I. Observation of two antigenic groups in Candida albicans. J. Bacteriol., 82, 570-573.
12. [12] Warnock, D.W., Speller, D.C.E., Day, J.K. & Farrell, A.J. (1979), Resistogram method for differentiation of strains of Candida albicans. J. Appl. Bacteriol., 46, 571-578.
13. [13] Phongpaichit, S., Mackenzie, D.W.R. & Fraser, C. (1987), Strain differentiation of Candida albicans by morphotyping. Epidemiol. Infect., 99, 421-428.
14. [14] Odds, F.C. & Abbott, A.B. (1983), Modification and extension of tests for differentiation of Candida species and strains. Sabouraudia, 21, 79-81.
15. [15] Polonelli, L., Archibusacci, C., Sestito, M. & Morace, G. (1983), Killer system: a simple method for differentiating Candida albicans strains. J. Clin. Microbiol., 17, 774-780.
16. [16] Lee, W., Burnie, J.P. & Matthews, R.C. (1986), Fingerprinting Candida albicans. J. Immunol. Methods, 93, 177-182.
17. [17] Scherer, S & Stevens, D.A. (1987), Application of DNA typing methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol., 25, 675-679.
18. [18] Olivo, P.D., Mc Manus, E.J., Riggsby,W.S. & Jones, J.M. (1987), Mitochondrial DNA polymorphism in Candida albicans. J. Infect. Dis., 156, 214-215.
19. [19] Magee, B.B. & Magee, P.T. (1987), Electrophoretic karyotypes and chromosome numbers in Candida species. J. Gen. Microbiol., 133, 425-430.
20. [20] Bostock, A., Khattak, N.M., Matthews, R. & Burnie, J. (1993), Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans. J. Gen. Microbiol., 139, 2179-2184.
21. [21] Burnie, J.P., Odds, F.C., Lee, W., Webster, C. & Williams, J.D. (1985), Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br. Med. J., 290, 746-748.
22. [22] Matthews, R.C. & Burnie, J.P. (1989), The rapid identification of outbreaks of systemic candidosis by DNA fingerprinting. Br. Med., J. 298, 354-357.
23. [23] Burnie, J.P., Lee, W., Williams, J.D., Matthews, R.C. & Odds, F.C. (1985), Control of an outbreak of systemic Candida albicans. Br. Med. J., 291, 1092-1093.
24. [24] Burnie, J.P., Matthews, R.C. & Lee, W. (1987), Four outbreaks of nosocomial systemic candidiasis. Epidemiol. Infect., 99, 201-211.
25. [25] Lee, W., Burnie, J.P., Matthews, R.C., Oppenheim, B.O. & Damani, N.N. (1991), Hospital outbreaks with yeasts. J. Hosp. Infect., 18, (Suppl.A), 237-249.
26. [26] Essayag, S.M., Baily, G.G., Denning, D.W. & Burnie, J.P. (1996), Karotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua. Int. J. Syst. Bacteriol., 46, 35-40.
27. [27] Matthews, R.C., Burnie, J.P., Smith, D. et al (1988), Candida and AIDS: evidence for protective antibody. Lancet, ii, 236-266.
28. [28] Whelan, W.L., Kirsch, D.R., Kwon-Chung, K., Wahl, S.M. & Smith, P.D.(1990), Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J. Infect. Dis., 162, 513-518.
29. [29] Powderley, W.G., Robinson, K. & Keath, E.J. (1993), Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J. Infect. Dis., 168, 463-466.
30. [30] Mata-Essayag, S., Burnie, J.P., Bailey, G. & Mandall, B. (1998), Genotyping fluconazole resistant Candida albicans from human immunodeficiency virus positive patients. Opportunistic Pathogen (in press).
31. [31] Matthews, R.C. & Burnie, J.P. (1998), The role of antibodies in protection against candidiasis. Res. Infect. Dis. (in press).
32. [32] Sturtevant, J. & Calderone, R. (1997), Candida albicans adhesins: biochemical aspects and virulence. Rev. Iberoam. Micol., 14, 90-97.
33. [33] Lee, K.K., Yu, L., Macdonald, D.L., Paranchych, W., Hodges, R.S. & Irvin, R.T. (1996), Anti-adhesin antibodies that recognize a receptor-binding motif (adhesintope) inhibit pilus/fimbrial-mediated adherence of Pseudomonas aeruginosa and Candida albicans to asialo-GM1 receptors and human buccal epithelial cell surface receptors. Can. J. Microbiol, 42, 479-486.
34. [34] Polonelli, L, Gerloni, M., Conti, S., Fisicaro, P., Cantelli, C., Portincasa, P., Almondo, F., Barea, P.L., Hernando, F.L. & Ponton, J. (1994), Heat shock mannoproteins as targets of secretory IgA in Candida albicans. J. Infect. Dis., 169, 1401-1405.
35. [35] Casanova, M., Martinez, J.P. & Chaffin, W.L. (1990), Fab fragments from a monoclonal antibody against germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans. Infect. Immun., 58, 3810-3812.
36. [36] Han, Y. & Cutler, J.E. (1995), Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714-2719.
37. [37] Han, Y. & Cutler, J.E. (1997), Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis., 175, 1169-1175.
38. [38] Caesar-TonThat, T.C. & Cutler, J.E. (1997), A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect. Immun., 65, 5354-5357.
39. [39] Cassone, A, Boccanera, M., Adriani, D., Santoni, G. & De Bernardis, F.(1995), Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun., 63, 2619-2624.
40. [40] Macdonald, F & Odds, F.C. (1980), Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J. Med. Microbiol., 13, 423-435.
41. [41] Borg, M. & Rüchel, R. (1990), Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J. Med. Vet. Mycol., 28, 3-14.
42. [42] Edison, A.M. & Manning-Zweerink, M. (1988), Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent. Infect. Immun., 56, 1388-1390.
43. [43] Hube, B., Monod, M., Scofield, D.A., Brown, A.J.P. & Gow, N.A.R. (1994), Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol., 14, 87-99.
44. [44] Ghadjari, A., Matthews, R.C. & Burnie, J.P. (1997), Epitope mapping Candida albicans proteinase (SAP2). FEMS Immunol. Med. Microbiol., 19, 115-123.
45. [45] Soll, D.R. (1992), Switching and its possible role in Candida pathogenesis, in "New Strategies in Fungal Disease" (J.E. Bennett, R.J. Hay & P.K. Peterson) (pp. 156-172). Churchill Livingstone, Edinburgh.
46. [46] Bonnefoy, S., Gysin, J., Blisnick, T., Guillotte, M., Carcy, B., da Silva, L.P. & Mercereau-Puijalon, O. (1994), Immunogenicity and antigenicity of Plasmodium falciparum protein fraction (90-110 kDa) able to protect squirrel monkeys against asexual blood stages. Vaccine, 12, 32-40.
47. [47] Matthews, R.C., Burnie, J.P. & Lee, W. (1991), The application of epitope mapping in the development of a new serological test for systemic candidosis. J. Immunol. Meth., 143, 73-79.
48. [48] Matthews, R.C., Burnie, J.P., Howat, D., Rowland, T. & Walton, F. (1991), Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology, 74, 20-24.
49. [49] Matthews, R.C., Hodgetts, S. & Burnie, J.P. (1995), Preliminary assessment of a human recombinant antibody to hsp90 in the treatment of murine invasive candidiasis. J. Infect. Dis., 171, 1668-1671.
50. [50] Hodgetts, S., Matthews, R.C., Morrissey, G., Mitsutake, K., Piper, P., Burnie, J.,P. (1996), Overexpression of Saccharomyces cerevisiae hsp90 enhances virulence of this yeast in mice. FEMS Immunol. Med. Microbiol., 16, 229-234.
51. [51] Matthews, R.C., Wells, C. & Burnie, J.P. (1988), Characterisation and cellular localisation of the immunodominant 47-Kilodalton antigen of Candida albicans. J. Med. Microbiol., 27, 227-232.
52. [52] LaValle, R., Bromuro, C., Ranucci, L., Muller, H.-M., Crisanti, A. & Cassone, A. (1995), Molecular cloning and expression of a 70-kilodalton heat shock protein of Candida albicans. Infect. Immun., 63, 4039-4045.
53. [53] Lopez-Ribot, J.L., Alloush, H.B., Masten, B.J. & LaJean Chaffin, W. (1996), Evidence for presence in the cell wall of Candida albicans of a protein related to the hsp70 family. Infect. Immun., 64, 3333-3340.